Areas of Research

Genetics of Cancer and Immunodeficiency

Humans make more than one million different immune responses. This vast diversity is driven by the complex development of lymphocytes; the capacity to mount a specific immune response lasts a lifetime and requires complex signaling pathways and rearrangements of DNA.  Lymphocyte development can go awry due to more than 50 known genetic defects in the immune system.  The lifelong DNA rearrangements in lymphocytes are error prone and can lead to consequent formation of lymphoid cancers (lymphomas).

Immunodeficiency disease, often serious, can result when gene defects hinder lymphocyte regulation or operation.  Understanding how defective versions of these genes lead to rare immunodeficiency diseases will enhance our understanding of the roles these genes normally play in the immune system.

Immunodeficiency investigators at PCMM are pursuing this fundamental scientific challenge:

Discovery of the products of defective genes and their effects on the immune system
Investigators in the genetics concentration have defined the following challenges:

  • Modeling the basis of immunological diversity
  • Developing mouse models for various types of lymphoma generation and development of other cancers
  • Mouse modeling for development and physiology of the immune system
  • Mouse modeling of tolerance related to autoimmunity

Related News and Announcements

DNA breaks in nerve cells' ancestors cluster in specific genes

Image: DNA breaks in nerve cells' ancestors cluster in specific genes

The genome of developing brain cells harbors 27 clusters, or hotspots, where its DNA is much more likely to break in some places than others,… Read Full Article »

Frederick Alt, PhD, awarded 2015 Szent-Gyorgyi Prize for Progress in Cancer Research

Image: Frederick Alt, PhD, awarded 2015 Szent-Gyorgyi Prize for Progress in Cancer Research

 

Frederick Alt, PhD, director of the Program in Cellular and Molecular Medicine at Boston Children's Hospital, has been honored with the 2015 Szent-Györgyi Prize for Progress in Cancer Research. Awarded by… Read Full Article »

On the hunt for gene editing's collateral damage

Image: On the hunt for gene editing's collateral damage

Labs the world over are jumping on the gene editing bandwagon (and into the inevitable patent arguments). And it's hard to blame them. As these technologies… Read Full Article »

Shedding light on AID off-targeting and lymphoma

Image: Shedding light on AID off-targeting and lymphoma

Researchers in the laboratory of Frederick Alt at the Howard Hughes Medical Institute and Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital, led by… Read Full Article »